Teva reports seventh straight quarter of growth
06.11.24 14:58 Uhr
Werbung
Werte in diesem Artikel
Aktien
16,00 EUR -0,25 EUR -1,54%
Indizes
18.878,7 PKT -87,4 PKT -0,46%
1.333,7 PKT 8,5 PKT 0,64%
The Israeli pharmaceutical company beat the analysts and has again raised 2024 revenue guidance, this time to $16.1-16.5 billion.Weiter zum vollständigen Artikel bei Globes
Quelle: Globes
Nachrichten zu Teva Pharmaceutical Industries Ltd. (spons. ADRs)
Analysen zu Teva Pharmaceutical Industries Ltd. (spons. ADRs)
| Datum | Rating | Analyst | |
|---|---|---|---|
| 19.07.2019 | Teva Pharmaceutical Industries Peer Perform | Wolfe Research | |
| 11.06.2019 | Teva Pharmaceutical Industries Underweight | Barclays Capital | |
| 03.06.2019 | Teva Pharmaceutical Industries Outperform | Oppenheimer & Co. Inc. | |
| 29.03.2019 | Teva Pharmaceutical Industries Market Perform | BMO Capital Markets | |
| 21.09.2018 | Teva Pharmaceutical Industries Perform | Oppenheimer & Co. Inc. |
| Datum | Rating | Analyst | |
|---|---|---|---|
| 03.06.2019 | Teva Pharmaceutical Industries Outperform | Oppenheimer & Co. Inc. | |
| 29.03.2019 | Teva Pharmaceutical Industries Market Perform | BMO Capital Markets | |
| 09.01.2018 | Teva Pharmaceutical Industries Buy | Mizuho | |
| 11.09.2017 | Teva Pharmaceutical Industries Buy | BTIG Research | |
| 17.07.2017 | Teva Pharmaceutical Industries Outperform | RBC Capital Markets |
| Datum | Rating | Analyst | |
|---|---|---|---|
| 19.07.2019 | Teva Pharmaceutical Industries Peer Perform | Wolfe Research | |
| 21.09.2018 | Teva Pharmaceutical Industries Perform | Oppenheimer & Co. Inc. | |
| 17.09.2018 | Teva Pharmaceutical Industries Neutral | BTIG Research | |
| 09.02.2018 | Teva Pharmaceutical Industries Hold | Gabelli & Co | |
| 09.02.2018 | Teva Pharmaceutical Industries Sector Perform | RBC Capital Markets |
| Datum | Rating | Analyst | |
|---|---|---|---|
| 11.06.2019 | Teva Pharmaceutical Industries Underweight | Barclays Capital | |
| 02.02.2018 | Teva Pharmaceutical Industries Sell | BTIG Research | |
| 03.11.2017 | Teva Pharmaceutical Industries Underperform | RBC Capital Markets | |
| 30.10.2017 | Teva Pharmaceutical Industries Underperform | RBC Capital Markets | |
| 18.09.2017 | Teva Pharmaceutical Industries Underperform | RBC Capital Markets |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Teva Pharmaceutical Industries Ltd. (spons. ADRs) nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen
Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"